AstraZeneca confirms delays to COVID-19 shots produced in Latin America
- Country:
- Mexico
AstraZeneca has confirmed setbacks to production of its COVID-19 vaccines in Latin America, excluding Brazil, but said it will still meet a commitment to deliver 150 million doses to the region this year.
The Anglo-Swedish drugmaker said in a statement shared with Reuters on Friday that lower-than-expected production, shortages of critical supplies and longer periods for regulatory approval had slowed the process.
ALSO READ
-
Rural Investment Can Unlock Growth Across Latin America and the Caribbean, Says IFAD
-
IFC and SMBC Launch $500m Facility to Help Small Suppliers Get Paid Faster
-
IDB Sets Out Education Roadmap to Close LAC Learning Gaps
-
IDB Forum Puts Latin America and Caribbean’s $1.4 Trillion Housing Needs in Focus
-
IAEA and IDB Join Forces to Expand Nuclear Energy in Latin America and Caribbean
Google News